The "Chart of the Day" is Isis Pharmaceuticals (ISIS), which showed up on Monday's Barchart "52-week High" list. Isis on Monday posted a new 1-year high of $9.42 and closed up 5.14%. TrendSpotter has been long since May 10 at $8.95. In recent news on the stock, Isis reported Q1 EPS of -24 cents, which was slightly better than expectations of -26 cents. Piper Jaffray on May 1 upgraded Isis to Overweight from Neutral and raised its price target to $15 from $10. Isis Pharmaceuticals, with a market cap of $900 million, is a leading genomics-based drug discovery and development company that is focused on RNA.
No comments:
Post a Comment